These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7845748)

  • 1. Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity.
    Linder N; Handsher R; Fruman O; Shiff E; Ohel G; Reichman B; Dagan R
    Pediatr Infect Dis J; 1994 Nov; 13(11):959-62. PubMed ID: 7845748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to poliomyelitis virus in cord blood of neonates born to from mothers in contact or not in contact with the wild virus.
    Lago PM; Escobar WA; Hernández PR; Elías MJ; Puente RP
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(3):315-9. PubMed ID: 2848883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of immunity in mothers of infants administered trivalent oral poliovirus vaccine.
    Dagan R; Fraser D; Handsher R
    Eur J Clin Microbiol Infect Dis; 1994 Dec; 13(12):1029-32. PubMed ID: 7889964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early immunization of neonates with trivalent oral poliovirus vaccine.
    Weckx LY; Schmidt BJ; Herrmann AA; Miyasaki CH; Novo NF
    Bull World Health Organ; 1992; 70(1):85-91. PubMed ID: 1314711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental transfer of maternal poliovirus antibodies in full-term and pre-term infants.
    Linder N; Taushtein I; Handsher R; Ohel G; Reichman B; Barzilai A; Kuint J; Davidovitch N; Mendelson E; Dagan R
    Vaccine; 1998; 16(2-3):236-9. PubMed ID: 9607036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A longitudinal study on maternal-fetal transfer of antibody against poliomyelitis].
    You E; Yang Q; Yang QL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Jun; 15(3):158-61. PubMed ID: 7834692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polio antibody outfit of newborns and infants born after 20 years of mass vaccination with live poliovaccine.
    Koza J; Matyásová I; Danes L; Skovránek V; Havelková M
    J Hyg Epidemiol Microbiol Immunol; 1984; 28(1):25-32. PubMed ID: 6325534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The humoral immune response to type 1 oral poliovirus vaccine in children previously immunized with enhanced potency inactivated poliovirus vaccine or live oral poliovirus vaccine.
    Modlin JF; Onorato IM; McBean AM; Albrecht P; Thoms ML; Nerhood L; Bernier R
    Am J Dis Child; 1990 Apr; 144(4):480-4. PubMed ID: 2157337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster immunization.
    Green MS; Handsher R; Cohen D; Melnick JL; Slepon R; Mendelsohn E; Danon YL
    Vaccine; 1993; 11(1):75-81. PubMed ID: 8381249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of passively transferred anti-poliovirus antibodies on seroconversion.
    Bavdekar SB; Naik S; Nadkarni SS; Kamat JR; Deshpande JM; Vaswani LK
    Indian J Pediatr; 1999; 66(1):45-8. PubMed ID: 10798035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules.
    Bandyopadhyay AS; Asturias EJ; O'Ryan M; Oberste MS; Weldon W; Clemens R; Rüttimann R; Modlin JF; Gast C
    Vaccine; 2017 Dec; 35(52):7283-7291. PubMed ID: 29150209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine.
    J Infect Dis; 1995 May; 171(5):1097-106. PubMed ID: 7751683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
    Ogra PL
    Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.
    Sutter RW; Suleiman AJ; Malankar PG; Mehta FR; Medany MA; Arif MA; Linkins RW; Pallansch MA; El-Bualy MS; Robertson SE
    J Infect Dis; 1997 Feb; 175 Suppl 1():S235-40. PubMed ID: 9203722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States.
    Chen RT; Hausinger S; Dajani AS; Hanfling M; Baughman AL; Pallansch MA; Patriarca PA
    JAMA; 1996 Jun; 275(21):1639-45. PubMed ID: 8637136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.
    Mulholland K; Suara RO; Siber G; Roberton D; Jaffar S; N'Jie J; Baden L; Thompson C; Anwaruddin R; Dinan L; Glezen WP; Francis N; Fritzell B; Greenwood BM
    JAMA; 1996 Apr; 275(15):1182-8. PubMed ID: 8609686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.